Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesPharmacy & Specialty DrugsHAP albuterol/metformin step therapy Coverage | Op…
    Ask Trek AI about this page
    CurrentHealth Alliance Plan (HAP)Policy N/A

    Albuterol step therapy (levalbuterol and metformin solution listed under Albuterol policy header)

    Customize your policy alerts

    Sign up for all Health Alliance Plan (HAP) policy alerts

    Know when Health Alliance Plan (HAP) releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Defines step therapy requirements for specific products (levalbuterol HFA and metformin 500 mg/5 ml oral solution) for new starts; applies to Health Alliance Plan members and prescribers submitting pharmacy claims.

    Policy Summary
    PayerHealth Alliance Plan (HAP)
    PolicyAlbuterol step therapy (levalbuterol and metformin solution listed under Albuterol policy header)
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateJul 1, 2026
    Next Review Date
    Key ActionFor new starts, submit evidence of a processed claim for the corresponding Step 1 product within the prior 120 days to allow processing of the Step 2 product.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    2Products with explicit step requirements listed
    120 daysPrior claim look-back period
    Step 2Step level required

    Coverage Criteria

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    inv-01: Levalbuterol HFA (45 mcg/actuation) - Initial coverage

    Covered when ALL of the following are met for levalbuterol HFA:

    Levalbuterol HFA step criteria: 1) New start for levalbuterol HFA; 2) A processed claim for albuterol HFA exists within the prior 120 days120 days

    Step 2 product processes only after Step 1 claim

    inv-02: Metformin 500 mg/5 ml oral solution - Initial coverage

    Covered when ALL of the following are met for metformin 500 mg/5 ml oral solution:

    Metformin solution step criteria: 1) New start for metformin oral solution; 2) A processed claim for metformin tablet exists within the prior 120 days120 days

    Step 2 product processes only after Step 1 claim

    Initial Therapy Requirements

    inv-12: Initial therapy step requirement — New start processing requirement

    For new starts only; the following must be met to process a Step 2 product:

    New start requirement: For new starts only, require a processed claim for the corresponding Step 1 product within the prior 120 days to process the Step 2 product.120 days

    Applicable examples: levalbuterol HFA requires prior albuterol HFA claim; metformin 500 mg/5 ml oral solution requires prior metformin tablet claim.

    Step Therapy Rules

    StepProductRequirement
    2
    LEVALBUTEROL HFA 45 MCG/ACTUATION AEROSOL INHALER
    For new starts only: will process only if a claim for albuterol HFA was processed within the prior 120 days.
    StepProductRequirement
    2
    metformin 500 mg/5 ml oral solution
    For new starts only: will process only if a claim for metformin tablet was processed within the prior 120 days.

    Coding / Look-back Period

    inv-03: Prior claim look-back — 120 days
    Prior claim look-back period120 days
    Applies toNew starts for levalbuterol HFA (45 mcg/actuation)
    Required prior productAlbuterol HFA (evidence of a processed claim within look-back period)

    Provider Actions & Documentation

    Prior Authorization

    Step 2 prior use requirement

    These products are designated Step 2 and have step therapy processing rules for new starts requiring prior use of the corresponding Step 1 product within 120 days.

    • Step level: Step 2
    • Look-back period: 120 days
    • Applies to new starts only
    Step Therapy

    Step therapy processing rule for new starts

    For new starts only, coverage/processing of the Step 2 product requires evidence of a claim for the corresponding Step 1 product within the prior 120 days (albuterol HFA for levalbuterol HFA; metformin tablet for metformin 500 mg/5 ml oral solution).

    • Requirement is limited to new starts
    • Required look-back: 120 days
    • Corresponding Step 1 product must have a processed claim
    Documentation Required

    Levalbuterol: require prior albuterol HFA claim

    Evidence of a processed claim for albuterol HFA within the prior 120 days is required for new starts of levalbuterol HFA.

    • Look-back period: 120 days
    • Applies only to new starts of levalbuterol HFA
    Documentation Required

    Metformin solution: require prior metformin tablet claim

    Evidence of a processed claim for metformin tablet within the prior 120 days is required for new starts of metformin 500 mg/5 ml oral solution.

    • Look-back period: 120 days
    • Applies only to new starts of metformin oral solution
    Denial Risk

    Levalbuterol prior claim requirement and denial risk

    Claims for levalbuterol HFA will be processed only if there is a claim for albuterol HFA in the past 120 days; absence of such a claim may result in denial or failure to process.

    • Processing contingent on a processed albuterol HFA claim within 120 days
    • No processing if prior claim not found for new starts
    Denial Risk

    Metformin solution prior claim requirement and denial risk

    Claims for metformin 500 mg/5 ml oral solution will be processed only if there is a claim for metformin tablet in the past 120 days; absence of such a claim may result in denial or failure to process.

    • Processing contingent on a processed metformin tablet claim within 120 days
    • No processing if prior claim not found for new starts

    Background

    This document lists the step therapy requirements for pharmacy products shown under the Albuterol policy heading. It applies to Health Alliance Plan members and prescribers submitting pharmacy claims and defines processing rules for new starts of the listed Step 2 products.

    Specifically, the policy designates the listed products as Step 2 and requires evidence of prior use of the corresponding Step 1 product within a 120-day look-back period for new starts. For example, claims for LEVALBUTEROL HFA 45 MCG/ACTUATION will process only if a claim for albuterol HFA was processed in the past 120 days, and claims for metformin 500 mg/5 ml oral solution will process only if a claim for a metformin tablet was processed in the past 120 days.

    Providers should confirm that a qualifying Step 1 claim exists within the 120-day prior-claim look-back when submitting requests for these Step 2 products to avoid denial or failure to process for new starts.

    Definitions

    inv-11: Designation indicating a non-first-line product that requires prior use of a Step 1 product — Step 2
    Step designationStep 2
    MeaningDesignation for a non-first-line product that requires prior use of a Step 1 product
    Applies to (listed products)Levalbuterol HFA 45 mcg/actuation; metformin 500 mg/5 ml oral solution
    Policy Summary
    PayerHealth Alliance Plan (HAP)
    PolicyAlbuterol step therapy (levalbuterol and metformin solution listed under Albuterol policy header)
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateJul 1, 2026
    Next Review Date
    Key ActionFor new starts, submit evidence of a processed claim for the corresponding Step 1 product within the prior 120 days to allow processing of the Step 2 product.
    SourceLink
    On This Page
    Coverage CriteriaInitial Therapy RequirementsStep Therapy RulesCoding / Look-back PeriodProvider Actions & DocumentationBackgroundDefinitions